Incyte Corp (INCY)

Despite Incyte Corporation’s underperformance relative to the broader S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.14% this morning as investors shifted their focus to a highly anticipated earnings report from AI darling Nvidia.

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.71%. Stocks on Tuesday...

Incyte suspended testing of a drug candidate acquired through its April acquisition of Escient Pharmaceuticals and abandoned development of another, undermining its diversification strategy.

The S&P 500 Index ($SPX ) (SPY ) today is down -0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. Stocks are mixed today, with...

The S&P 500 Index ($SPX ) (SPY ) today is down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.40%. Stocks are retreating today,...

December S&P 500 E-Mini futures (ESZ24) are down -0.40%, and December Nasdaq 100 E-Mini futures (NQZ24) are down -0.32% this morning as risk sentiment took a hit after Russian President Vladimir Putin...

Incyte: Q3 Earnings Snapshot

Incyte will release its third-quarter earnings later this month, and analysts anticipate a double-digit profit growth.